Evaluation of Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam in Healthy Volunteers After Oral Single and Multiple Ascending Dosing of KAND145
Clinical trial NCT06063343 · COMPLETED
Trial details
- NCT number
- NCT06063343
- Sponsor
- Novakand Pharma AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-09
- Primary completion
- 2024-04-08
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.